Company news

Share this article:
Validus Pharmaceuticals announced that it has acquired bipolar disorder treatment Equetro (carbamazepine) extended release capsules from Shire. Validus Pharmaceuticals will begin active promotion of Equetro during the US Psychiatric & Mental Health Congress in Orlando, FL, in early October.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.